35 Publiek-private partnerschappen
  • Missies
  • Sleuteltechnologieën
  • Fase

AMR-Global

  • Coalition building
  • Missie V: Betere bescherming tegen gezondheidsdreigingen
  • Mission I: Lifestyle and living environment
AMR-Global is an internationally oriented public private collaboration to bring feasible, affordable and necessary solutions to curb AMR to the international market.

Animal Free Innovations

  • Mission III: Participating with a disease or disability
  • Mission IV: Quality of life for people with dementia
  • Stabilisation
Animal Free Innovations aims for innovative, patient-based methods to predict drug efficacy: better for man and animals.

BENEFIT (part of DCVA)

  • Mission I: Lifestyle and living environment
  • Mission III: Participating with a disease or disability
BENEFIT tries to make healthy living attractive by rewarding patients for healthy lifestyle activities.

Cluster Medical Robotics

  • Coalition building
  • Mission II: Care in the living environment
  • Mission III: Participating with a disease or disability
Improving surgical and rehabilitation care by providing advanced robot technology.

CONTRAST (part of DCVA)

  • Mission II: Care in the living environment
  • Mission III: Participating with a disease or disability
Unique nationwide collaboration of clinical and translational scientists who act together to improve the treatment of acute stroke.

Dutch CardioVascular Alliance (DCVA)

  • Mission II: Care in the living environment
  • Mission III: Participating with a disease or disability
  • Up-and-running
DCVA focuses on earlier recognition of disease and rapid translation of excellent science into health improvement.

EMPOWER

  • Coalition building
  • Mission II: Care in the living environment
  • Mission III: Participating with a disease or disability
EMPOWER supports people with a chronic disease in self-care and social participation by employing learning principles.

European Lead Factory (ELF)

  • Mission III: Participating with a disease or disability
  • Mission IV: Quality of life for people with dementia
  • Up-and-running
Seeding Tomorrow’s Priority Medicine